Image
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login

Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients

admin September 2, 2008 Portfolio News

Learn More-External Link

Back

Topics

News Archives

Image
Privacy Policy Terms of Use©2022 Lumira Ventures
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login